Kwasi leverages the unique capabilities of biomaterials to both develop new therapies and enhance the efficacy of existing therapies in the areas of cancer, infectious disease and regeneration. He completed his PhD training in Dr. David Mooney’s lab at the Wyss Institute, which was focused on applying the principles of immunology and engineering to modulating T cell therapies.